( MENAFN - PR Newswire) The cloud-based platform enhances FibroScan® capabilities, providing advanced tools for data-driven liver disease management PARIS, Nov. 4, 2024 /PRNewswire/ -- Liver disease affects an estimated 1.5 billion people worldwide, with many cases going undiagnosed until it's too late.
As liver conditions like metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) become more common, the need for early detection and proactive management has never been more urgent. To address this global health crisis, Echosens has launched its Liver Health Management (LHM) platform -a cloud-based solution designed to streamline liver disease care for healthcare providers in diverse clinical environments. The LHM platform integrates seamlessly with Echosens' FibroScan® technology, offering automated result transfers, biological marker-enhanced exams, and interpretation tools that support more informed, data-driven decision-making.
"The LHM platform is designed to meet the growing needs of healthcare providers who are seeing an increase in patients with liver disease," said Dominique Legros, Group CEO of Echosens. "By connecting FibroScan® with the LHM platform, providers can access real-time insights and deliver more precise, data-driven care. The platform unlocks next-level liver disease management, enhancing efficiency and empowering clinicians to streamline workflows, improve patient outcomes, and sta.
